ID   SIN1_RAT                Reviewed;         522 AA.
AC   Q6AYF1;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   29-MAY-2024, entry version 118.
DE   RecName: Full=Target of rapamycin complex 2 subunit MAPKAP1;
DE            Short=TORC2 subunit MAPKAP1;
DE   AltName: Full=Mitogen-activated protein kinase 2-associated protein 1;
DE   AltName: Full=Stress-activated map kinase-interacting protein 1;
DE            Short=SAPK-interacting protein 1;
GN   Name=Mapkap1; Synonyms=Mip1, Sin1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Subunit of mTORC2, which regulates cell growth and survival
CC       in response to hormonal signals. mTORC2 is activated by growth factors,
CC       but, in contrast to mTORC1, seems to be nutrient-insensitive. mTORC2
CC       seems to function upstream of Rho GTPases to regulate the actin
CC       cytoskeleton, probably by activating one or more Rho-type guanine
CC       nucleotide exchange factors. mTORC2 promotes the serum-induced
CC       formation of stress-fibers or F-actin. mTORC2 plays a critical role in
CC       AKT1 'Ser-473' phosphorylation, which may facilitate the
CC       phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDK1
CC       which is a prerequisite for full activation. mTORC2 regulates the
CC       phosphorylation of SGK1 at 'Ser-421'. mTORC2 also modulates the
CC       phosphorylation of PRKCA on 'Ser-657'. Within mTORC2, MAPKAP1 is
CC       required for complex formation and mTORC2 kinase activity. MAPKAP1
CC       inhibits MAP3K2 by preventing its dimerization and autophosphorylation.
CC       Inhibits HRAS and KRAS signaling. Enhances osmotic stress-induced
CC       phosphorylation of ATF2 and ATF2-mediated transcription. Involved in
CC       ciliogenesis, regulates cilia length through its interaction with
CC       CCDC28B independently of mTORC2 complex (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Part of the mammalian target of rapamycin complex 2 (mTORC2)
CC       which contains MTOR, MLST8, PRR5, RICTOR, MAPKAP1 and DEPTOR. Contrary
CC       to mTORC1, mTORC2 does not bind to and is not sensitive to FKBP12-
CC       rapamycin. Interacts with ATF2, MAP3K2 and MAPK8. Interacts with GTP-
CC       bound HRAS and KRAS. Interacts with IFNAR2, NBN and SGK1. Interacts
CC       with CCDC28B (By similarity). {ECO:0000250|UniProtKB:Q9BPZ7}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}. Cytoplasmic vesicle {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SIN1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC079073; AAH79073.1; -; mRNA.
DR   RefSeq; NP_001011964.1; NM_001011964.1.
DR   RefSeq; XP_006234011.1; XM_006233949.2.
DR   RefSeq; XP_006234012.1; XM_006233950.2.
DR   RefSeq; XP_017447140.1; XM_017591651.1.
DR   RefSeq; XP_017447141.1; XM_017591652.1.
DR   AlphaFoldDB; Q6AYF1; -.
DR   SMR; Q6AYF1; -.
DR   STRING; 10116.ENSRNOP00000023889; -.
DR   iPTMnet; Q6AYF1; -.
DR   PhosphoSitePlus; Q6AYF1; -.
DR   PaxDb; 10116-ENSRNOP00000023889; -.
DR   Ensembl; ENSRNOT00000119554.1; ENSRNOP00000078499.1; ENSRNOG00000017583.8.
DR   Ensembl; ENSRNOT00055010359; ENSRNOP00055008037; ENSRNOG00055006373.
DR   Ensembl; ENSRNOT00060048240; ENSRNOP00060040156; ENSRNOG00060027796.
DR   Ensembl; ENSRNOT00065045928; ENSRNOP00065037691; ENSRNOG00065026595.
DR   GeneID; 296648; -.
DR   KEGG; rno:296648; -.
DR   AGR; RGD:1305363; -.
DR   CTD; 79109; -.
DR   RGD; 1305363; Mapkap1.
DR   eggNOG; KOG3739; Eukaryota.
DR   GeneTree; ENSGT00390000000642; -.
DR   HOGENOM; CLU_514767_0_0_1; -.
DR   InParanoid; Q6AYF1; -.
DR   OMA; NAKFWPQ; -.
DR   OrthoDB; 49453at2759; -.
DR   PhylomeDB; Q6AYF1; -.
DR   TreeFam; TF315174; -.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-RNO-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-RNO-6804757; Regulation of TP53 Degradation.
DR   PRO; PR:Q6AYF1; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000017583; Expressed in kidney and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0031932; C:TORC2 complex; ISO:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0070300; F:phosphatidic acid binding; ISO:RGD.
DR   GO; GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; ISO:RGD.
DR   GO; GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; ISO:RGD.
DR   GO; GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; ISO:RGD.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0031267; F:small GTPase binding; ISO:RGD.
DR   GO; GO:0046580; P:negative regulation of Ras protein signal transduction; ISO:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:1900407; P:regulation of cellular response to oxidative stress; ISO:RGD.
DR   GO; GO:0038203; P:TORC2 signaling; IBA:GO_Central.
DR   CDD; cd13331; PH_Avo1; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR031567; CRIM_dom.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR008828; Sin1/Avo1.
DR   InterPro; IPR032679; Sin1_N.
DR   InterPro; IPR031313; Sin1_PH_dom.
DR   PANTHER; PTHR13335; TARGET OF RAPAMYCIN COMPLEX 2 SUBUNIT MAPKAP1; 1.
DR   PANTHER; PTHR13335:SF1; TARGET OF RAPAMYCIN COMPLEX 2 SUBUNIT MAPKAP1; 1.
DR   Pfam; PF16978; CRIM; 1.
DR   Pfam; PF05422; SIN1; 1.
DR   Pfam; PF16979; SIN1_PH; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Cell membrane; Cytoplasmic vesicle; Membrane; Nucleus;
KW   Phosphoprotein; Reference proteome; Stress response.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BPZ7"
FT   CHAIN           2..522
FT                   /note="Target of rapamycin complex 2 subunit MAPKAP1"
FT                   /id="PRO_0000328036"
FT   REGION          2..267
FT                   /note="Interaction with NBN"
FT                   /evidence="ECO:0000250"
FT   REGION          2..184
FT                   /note="Interaction with MAP3K2"
FT                   /evidence="ECO:0000250"
FT   REGION          38..59
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          468..522
FT                   /note="Interaction with ATF2"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BPZ7"
FT   MOD_RES         186
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BPZ7"
FT   MOD_RES         510
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BPZ7"
SQ   SEQUENCE   522 AA;  59043 MW;  7F96C228E60A8B88 CRC64;
     MAFLDNPTII LAHIRQSHVT SDDTGMCEMV LIDHDVDLEK THPPSVPGDS GSEVQGSSGE
     TQGYIYAQSV DITSSWDFGI RRRSNTAQRL ERLRKERQNQ IKCKNIQWKE RNSKQSAQEL
     KSLFEKKSLK EKPPSSGKQS ILSVRLEQCP LQLNNPFNEY SKFDGKGHVG TTATKKIDVY
     LPLHSSQDRL LPMTVVTMAS ARVQDLIGLI CWQYTSEGRE PKLNDNVSAY CLHIAEDDGE
     VDTDFPPLDS NEPIHKFGFS TLALVEKYSS PGLTSKESLF VRINAAHGFS LIQVDNTKVT
     MKEILLKALK RRKGSQKISG PQYRLEKQSE PNIGVDLEST LESQNAWEFC LVRENSSRAD
     GVFEEDSQID IATVQDMLSS HHYKSFKVSM IHRLRFTTDV QLGISGDKVE IDPVTNQKAS
     TKFWIKQKPI SIDCDLLCAC DLAEEKSPSH AVFKLTYLSS HDYKHLYFES DAATVSEIVL
     KVNYILESRA STARADYFAQ KQRKLNRRTS FSFQKEKKSG QQ
//
